Multimorbidity in randomized controlled trials of behavioral interventions: A systematic review

Health Psychology

Volumn 38, Issue 9, 2019, Pages 831-839

  Stoll, Carolyn R T ^a   Izadi, Sonya ^a   Fowler, Susan ^a,c   Philpott Streiff, Sydney ^a   Green, Paige ^b   Suls, Jerry ^b   Winter, Anke C ^a,d   Colditz, Graham A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^d Fresenius Medical Care AG   (Germany)

Author keywords

Behavioral medicine; Multimorbidity; Randomized clinical trials; Systematic review

Indexed keywords

ARTICLE; BEHAVIOR THERAPY; BODY WEIGHT MANAGEMENT; CHRONIC DISEASE; COGNITIVE BEHAVIORAL THERAPY; COMORBIDITY; HUMAN; MINDFULNESS; MOTIVATIONAL INTERVIEWING; MULTIPLE CHRONIC CONDITIONS; PATIENT COMPLIANCE; PSYCHOLOGICAL WELL-BEING; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING CESSATION; SYSTEMATIC REVIEW;

EID: 85065148904     PISSN: 02786133     EISSN: 19307810     Source Type: Journal    
DOI: 10.1037/hea0000726     Document Type: Article

References (26)

1. Boyd, C. M., Vollenweider, D., & Puhan, M. A. (2012). Informing evidence-based decision-making for patients with comorbidity: Availability of necessary information in clinical trials for chronic diseases. PLoS ONE, 7, e41601. http://dx.doi.org/10.1371/journal.pone.0041601
2. Buffel du Vaure, C., Dechartres, A., Battin, C., Ravaud, P., & Boutron, I. (2016). Exclusion of patients with concomitant chronic conditions in ongoing randomised controlled trials targeting 10 common chronic conditions and registered at ClinicalTrials.gov: A systematic review of registration details. British Medical Journal Open, 6, e012265. http://dx .doi.org/10.1136/bmjopen-2016-012265
3. Burke, J. F., Sussman, J. B., Kent, D. M., & Hayward, R. A. (2015). Three simple rules to ensure reasonably credible subgroup analyses. British Medical Journal, 351, h5651. http://dx.doi.org/10.1136/bmj.h5651
4. Chan, A. W., & Altman, D. G. (2005). Epidemiology and reporting of randomised trials published in PubMed journals. The Lancet, 365, 1159-1162. http://dx.doi.org/10.1016/S0140-6736(05)71879-1
5. Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40, 373-383. http://dx.doi.org/10.1016/0021-9681(87)90171-8
6. de Groot, V., Beckerman, H., Lankhorst, G. J., & Bouter, L. M. (2003). How to measure comorbidity. a critical review of available methods. Journal of Clinical Epidemiology, 56, 221-229. http://dx.doi.org/10 .1016/S0895-4356(02)00585-1
7. Diederichs, C., Berger, K., & Bartels, D. B. (2011). The measurement of multiple chronic diseases: A systematic review on existing multimorbidity indices. The Journals of Gerontology Series A, Biological Sciences and Medical Sciences, 66A, 301-311. http://dx.doi.org/10.1093/gerona/glq208
8. Gabler, N. B., Duan, N., Raneses, E., Suttner, L., Ciarametaro, M., Cooney, E., . . . Kravitz, R. L. (2016). No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals. Trials, 17, 320. http://dx.doi.org/10.1186/s13063-016-1447-5
9. Goodman, R. A., Posner, S. F., Huang, E. S., Parekh, A. K., & Koh, H. K. (2013). Defining and measuring chronic conditions: Imperatives for research, policy, program, and practice. Preventing Chronic Disease, 10, E66. http://dx.doi.org/10.5888/pcd10.120239
10. Higgins, J. P., Altman, D. G., Gøtzsche, P. C., Jüni, P., Moher, D., Oxman, A. D., . . . the Cochrane Statistical Methods Group. (2011). The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. British Medical Journal, 343, d5928. http://dx.doi.org/10.1136/bmj.d5928
11. Hopewell, S., Dutton, S., Yu, L. M., Chan, A. W., & Altman, D. G. (2010). The quality of reports of randomised trials in 2000 and 2006: Comparative study of articles indexed in PubMed. British Medical Journal, 340, c723. http://dx.doi.org/10.1136/bmj.c723
12. Jadad, A. R., To, M. J., Emara, M., & Jones, J. (2011). Consideration of multiple chronic diseases in randomized controlled trials. Journal of the American Medical Association, 306, 2670-2672. http://dx.doi.org/10 .1001/jama.2011.1886
13. Kent, D. M., Rothwell, P. M., Ioannidis, J. P., Altman, D. G., & Hayward, R. A. (2010). Assessing and reporting heterogeneity in treatment effects in clinical trials: A proposal. Trials, 11, 85. http://dx.doi.org/10.1186/1745-6215-11-85
14. Loudon, K., Treweek, S., Sullivan, F., Donnan, P., Thorpe, K. E., & Zwarenstein, M. (2015). The PRECIS-2 tool: Designing trials that are fit for purpose. British Medical Journal, 350, h2147. http://dx.doi.org/10 .1136/bmj.h2147
15. Mokdad, A. H., Marks, J. S., Stroup, D. F., & Gerberding, J. L. (2004). Actual causes of death in the United States, 2000. Journal of the American Medical Association, 291, 1238-1245. http://dx.doi.org/10 .1001/jama.291.10.1238
16. National Center for Health Statistics. (2015). Health, United States, 2014: With Special Feature on Adults Aged 55-64. Hyattsville, MD
17. Ortman, J. M., Velkoff, V. A., & Hogan, H. (2014). An aging nation: The older population in the United States (pp. 25-1140). Washington, DC: U.S. Census Bureau
18. Parekh, A. K., & Barton, M. B. (2010). The challenge of multiple comorbidity for the U.S. health care system. Journal of the American Medical Association, 303, 1303-1304. http://dx.doi.org/10.1001/jama.2010.381
19. Parekh, A. K., Goodman, R. A., Gordon, C., Koh, H. K., & the HHS Interagency Workgroup on Multiple Chronic Conditions. (2011). Managing multiple chronic conditions: A strategic framework for improving health outcomes and quality of life. Public Health Reports, 126, 460-471. http://dx.doi.org/10.1177/003335491112600403
20. Thorpe, K. E., Zwarenstein, M., Oxman, A. D., Treweek, S., Furberg, C. D., Altman, D. G., . . . Chalkidou, K. (2009). A pragmaticexplanatory continuum indicator summary (PRECIS): A tool to help trial designers. Journal of Clinical Epidemiology, 62, 464-475. http://dx.doi .org/10.1016/j.jclinepi.2008.12.011
21. Trask, P. C., Schwartz, S. M., Deaner, S. L., Paterson, A. G., Johnson, T., Rubenfire, M., & Pomerleau, O. F. (2002). Behavioral medicine: The challenge of integrating psychological and behavioral approaches into primary care. Effective Clinical Practice, 5, 75-83
22. Van Spall, H. G., Toren, A., Kiss, A., & Fowler, R. A. (2007). Eligibility criteria of randomized controlled trials published in high-impact general medical journals: A systematic sampling review. Journal of the American Medical Association, 297, 1233-1240. http://dx.doi.org/10.1001/jama.297.11.1233
23. Varadhan, R., Segal, J. B., Boyd, C. M., Wu, A. W., & Weiss, C. O. (2013). A framework for the analysis of heterogeneity of treatment effect in patient-centered outcomes research. Journal of Clinical Epidemiology, 66, 818-825. http://dx.doi.org/10.1016/j.jclinepi.2013.02.009
24. Vogeli, C., Shields, A. E., Lee, T. A., Gibson, T. B., Marder, W. D., Weiss, K. B., & Blumenthal, D. (2007). Multiple chronic conditions: Prevalence, health consequences, and implications for quality, care management, and costs. Journal of General Internal Medicine, 22(Suppl. 3), 391-395. http://dx.doi.org/10.1007/s11606-007-0322-1
25. Weiss, C. O., Varadhan, R., Puhan, M. A., Vickers, A., Bandeen-Roche, K., Boyd, C. M., & Kent, D. M. (2014). Multimorbidity and evidence generation. Journal of General Internal Medicine, 29, 653-660. http://dx.doi.org/10.1007/s11606-013-2660-5
26. Zulman, D. M., Sussman, J. B., Chen, X., Cigolle, C. T., Blaum, C. S., & Hayward, R. A. (2011). Examining the evidence: A systematic review of the inclusion and analysis of older adults in randomized controlled trials. Journal of General Internal Medicine, 26, 783-790. http://dx.doi.org/10 .1007/s11606-010-1629-x